Expert Review of Anticancer Therapy

Published by Taylor & Francis Group

United Kingdom · Lung Cancer Treatments and Mutations

Journal at a glance

ISSN

1473-7140

Publisher

Taylor & Francis Group

Country

United Kingdom

Language

en

Also known as: Expert Rev Anticancer Ther (Abbreviation)

Indexing

• Web of Science (SCIE): Indexed
• Scopus: Indexed
• Medline: Active
• Pubmed: Active

Metrics

Subjects

• Lung Cancer Treatments and Mutations
• Cancer Immunotherapy and Biomarkers
• Bladder and Urothelial Cancer Treatments
• Renal cell carcinoma treatment
• Cancer Genomics and Diagnostics
• Prostate Cancer Treatment and Research
• Lung Cancer Research Studies

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Angiosarcoma: adaptive designs leveraging vascular biology and antiangiogenic repurposing (2026)
• Portal vein resection in pancreatic cancer: from technical feasibility to biological patient selection (2026)
• The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches (2026)
• An evaluation of retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal (2026)
• Association of neoadjuvant chemotherapy with outcomes in patients with elevated preoperative Ca 19–9 undergoing pancreatic ductal adenocarcinoma resection (2026)

Similar journals

• Future Oncology — United Kingdom · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same country
• JAMA Oncology — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total
• Clinical Lung Cancer — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total
• JCO Precision Oncology — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total
• Cancer Diagnosis and Prognosis — Greece · — · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Lung Cancer Research Studies, 4 shared subjects in total
• Lung Cancer: Targets and Therapy — New Zealand · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total

Sources: OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate), Scopus · Last verified 2026-09-05

Journal homepage